Drugnews|藥時事

Toray Industries, Inc.

東麗

Licensing announcements since 2025

DateCounterpartyAsset / platformUpfrontNear-termPotential totalStage at announcement
2026-03-05Immunis, Inc.IMM02-KORA / KORAIND submitted; Phase 1 planned for Parkinson-related dyskinesia